Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Regulation
4 Regulatory Developments to Follow in 2023
Federal government regulators are taking aggressive stances to protect workers, ensure fair markets, and keep investors informed.
By
Vincent Ryan
| January 31, 2023
Read More
Resources
CFO Live
2022 Survey
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
2022 Survey
Sign Up
Sponsored by
Immunomedics
Risk & Compliance
Pharma CFO Charged With Insider Trading
Usama Malik allegedly gave nonpublic information about an Immunomedics drug to his then-girlfriend while he was the firm's CFO.
By
Matthew Heller
| December 3, 2021
Read More
M&A
Gilead to Buy Cancer Drugmaker for $21 Billion
The acquisition of Immunomedics "represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio."
By
Matthew Heller
| September 14, 2020
Read More